Review



cervical cancer cell lines siha  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC cervical cancer cell lines siha
    Cervical Cancer Cell Lines Siha, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2611 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cervical cancer cell lines siha/product/ATCC
    Average 99 stars, based on 2611 article reviews
    cervical cancer cell lines siha - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    ATCC cervical cancer cell lines siha
    Cervical Cancer Cell Lines Siha, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cervical cancer cell lines siha/product/ATCC
    Average 99 stars, based on 1 article reviews
    cervical cancer cell lines siha - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC siha cell lines
    Siha Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/siha cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    siha cell lines - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC inhibited siha cc cell proliferation
    Inhibited Siha Cc Cell Proliferation, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inhibited siha cc cell proliferation/product/ATCC
    Average 99 stars, based on 1 article reviews
    inhibited siha cc cell proliferation - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC siha cells
    Siha Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/siha cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    siha cells - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    siha  (ATCC)
    99
    ATCC siha
    Impact of BYL-719 on the expression of target proteins in cervical cancer cell lines. (A, <t>B)</t> <t>CaSki</t> cells treated with BYL-719 show reduced levels of PD-L1, YAP1, EGFR, CTGF, Integrin, and HPV16 E7. In Panel B cells were treated with 5 uM BYL-719, washed at 24h and place in 0, 1 or 5 uM drug. (exposure time, 2 min). (C) BYL-719-treated <t>ME180</t> cells show decreased levels of PD-L1 and CTGF. (D) SNU-17 cells also show reduced levels of these proteins after treatment (exposure time, 5 min). (E) <t>SiHa</t> (PIK3CA wild-type) shows no reduction in PD-L1 or HPV16 E7 after treatment with BYL-719 (exposure time, 3 minutes). (F) Cell proliferation plot of SNU-17 cells treated with BYL-719 (G). SiHa cells treated with BYL719. *=P<0.05, **=P< 0.01, ***=P<0.001.
    Siha, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/siha/product/ATCC
    Average 99 stars, based on 1 article reviews
    siha - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC cervical carcinoma cell line siha
    Impact of BYL-719 on the expression of target proteins in cervical cancer cell lines. (A, <t>B)</t> <t>CaSki</t> cells treated with BYL-719 show reduced levels of PD-L1, YAP1, EGFR, CTGF, Integrin, and HPV16 E7. In Panel B cells were treated with 5 uM BYL-719, washed at 24h and place in 0, 1 or 5 uM drug. (exposure time, 2 min). (C) BYL-719-treated <t>ME180</t> cells show decreased levels of PD-L1 and CTGF. (D) SNU-17 cells also show reduced levels of these proteins after treatment (exposure time, 5 min). (E) <t>SiHa</t> (PIK3CA wild-type) shows no reduction in PD-L1 or HPV16 E7 after treatment with BYL-719 (exposure time, 3 minutes). (F) Cell proliferation plot of SNU-17 cells treated with BYL-719 (G). SiHa cells treated with BYL719. *=P<0.05, **=P< 0.01, ***=P<0.001.
    Cervical Carcinoma Cell Line Siha, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cervical carcinoma cell line siha/product/ATCC
    Average 99 stars, based on 1 article reviews
    cervical carcinoma cell line siha - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    htb  (ATCC)
    99
    ATCC htb
    Impact of BYL-719 on the expression of target proteins in cervical cancer cell lines. (A, <t>B)</t> <t>CaSki</t> cells treated with BYL-719 show reduced levels of PD-L1, YAP1, EGFR, CTGF, Integrin, and HPV16 E7. In Panel B cells were treated with 5 uM BYL-719, washed at 24h and place in 0, 1 or 5 uM drug. (exposure time, 2 min). (C) BYL-719-treated <t>ME180</t> cells show decreased levels of PD-L1 and CTGF. (D) SNU-17 cells also show reduced levels of these proteins after treatment (exposure time, 5 min). (E) <t>SiHa</t> (PIK3CA wild-type) shows no reduction in PD-L1 or HPV16 E7 after treatment with BYL-719 (exposure time, 3 minutes). (F) Cell proliferation plot of SNU-17 cells treated with BYL-719 (G). SiHa cells treated with BYL719. *=P<0.05, **=P< 0.01, ***=P<0.001.
    Htb, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/htb/product/ATCC
    Average 99 stars, based on 1 article reviews
    htb - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    Impact of BYL-719 on the expression of target proteins in cervical cancer cell lines. (A, B) CaSki cells treated with BYL-719 show reduced levels of PD-L1, YAP1, EGFR, CTGF, Integrin, and HPV16 E7. In Panel B cells were treated with 5 uM BYL-719, washed at 24h and place in 0, 1 or 5 uM drug. (exposure time, 2 min). (C) BYL-719-treated ME180 cells show decreased levels of PD-L1 and CTGF. (D) SNU-17 cells also show reduced levels of these proteins after treatment (exposure time, 5 min). (E) SiHa (PIK3CA wild-type) shows no reduction in PD-L1 or HPV16 E7 after treatment with BYL-719 (exposure time, 3 minutes). (F) Cell proliferation plot of SNU-17 cells treated with BYL-719 (G). SiHa cells treated with BYL719. *=P<0.05, **=P< 0.01, ***=P<0.001.

    Journal: medRxiv

    Article Title: A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy

    doi: 10.64898/2026.01.21.26344562

    Figure Lengend Snippet: Impact of BYL-719 on the expression of target proteins in cervical cancer cell lines. (A, B) CaSki cells treated with BYL-719 show reduced levels of PD-L1, YAP1, EGFR, CTGF, Integrin, and HPV16 E7. In Panel B cells were treated with 5 uM BYL-719, washed at 24h and place in 0, 1 or 5 uM drug. (exposure time, 2 min). (C) BYL-719-treated ME180 cells show decreased levels of PD-L1 and CTGF. (D) SNU-17 cells also show reduced levels of these proteins after treatment (exposure time, 5 min). (E) SiHa (PIK3CA wild-type) shows no reduction in PD-L1 or HPV16 E7 after treatment with BYL-719 (exposure time, 3 minutes). (F) Cell proliferation plot of SNU-17 cells treated with BYL-719 (G). SiHa cells treated with BYL719. *=P<0.05, **=P< 0.01, ***=P<0.001.

    Article Snippet: CC cell lines, including CaSki (ATCC Cat# CRM-CRL-1550_Ca Ski, RRID: CVCL_1100), SiHa (ATCC Cat# HTB-35_SiHa, RRID: CVCL_0032 and ME180 (ATCC Cat# HTB-33_ME-180, RRID: CVCL_1401), C33A (ATCC CRM-HTB-31, RRID:CVCL_1094) were obtained from ATCC.

    Techniques: Expressing